Preventing microalbuminuria with benazepril, valsartan, and benazepril–valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study

BACKGROUND: Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) prevent microalbuminuria in normoalbuminuric type 2 diabetic patients. We assessed whether combined therapy with the 2 medications may prevent microalbuminuria better than ACE inhibitor or ARB monothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggenenti, Piero, Cortinovis, Monica, Parvanova, Aneliya, Trillini, Matias, Iliev, Ilian P., Bossi, Antonio C., Belviso, Antonio, Aparicio, Maria C., Trevisan, Roberto, Rota, Stefano, Perna, Annalisa, Peracchi, Tobia, Rubis, Nadia, Martinetti, Davide, Prandini, Silvia, Gaspari, Flavio, Carrara, Fabiola, De Cosmo, Salvatore, Tonolo, Giancarlo, Mangili, Ruggero, Remuzzi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279302/
https://www.ncbi.nlm.nih.gov/pubmed/34260595
http://dx.doi.org/10.1371/journal.pmed.1003691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279302/
https://www.ncbi.nlm.nih.gov/pubmed/34260595
http://dx.doi.org/10.1371/journal.pmed.1003691

Ejemplares similares